Publications by authors named "Robyn Parks"

Claim this Profile
E
Educational cost-effective intervention to reduce pathologist's peripheral blood smears reviews with non-contributory findings: an academic institution experience.
Trang K Lollie, Robyn Parks, Lissette Bakic, Alyssa Ziman, Sheeja Pullarkat

J Clin Pathol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma 1 Transcription Factor Is Superior to CD138 as a Marker of Plasma Cells in Endometrium.
Robyn N Parks, Christopher J Kim, Zain A Al-Safi, Abigail A Armstrong, Temeka Zore

Int J Surg Pathol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 44-year-old female with familial Mediterranean fever, cardiomyopathy and end stage renal disease.
Shino Magaki, Robyn Parks, Harry V Vinters, Negar Khanlou

Brain Pathol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine.
Maria Omsland, Cynthia Pise-Masison, Dai Fujikawa, Veronica Galli, Claudio Fenizia, Robyn Washington Parks

Sci Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 44-Year-Old Female with Familial Mediterranean Fever, Cardiomyopathy and End Stage Renal Disease.
Shino Magaki, Robyn Parks, Harry V Vinters, Negar Khanlou

Brain Pathol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series of patients with ruptured abdominal aortic aneurysm.
Taylor Spencer, Rushad Juyia, Robyn Parks, Matthew Hodapp

West J Emerg Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.
Marcin Moniuszko, Namal P M Liyanage, Melvin N Doster, Robyn Washington Parks, Kamil Grubczak

AIDS Res Hum Retroviruses· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.
Claudio Fenizia, Martina Fiocchi, Kathryn Jones, Robyn Washington Parks, Michele Ceribelli

J Virol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques.
Izabela Bialuk, Stephen Whitney, Vibeke Andresen, Ruth H Florese, Janos Nacsa, Robyn Washington Parks

Vaccine· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smallpox vaccine safety is dependent on T cells and not B cells.
Shari N Gordon, Valentina Cecchinato, Vibeke Andresen, Jean-Michel Heraud, Anna Hryniewicz, Robyn Washington Parks

J Infect Dis· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.
Valerio W Valeri, Anna Hryniewicz, Vibeke Andresen, Kathy Jones, Claudio Fenizia, Robyn Washington Parks

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.
Shari N Gordon, Anna R Weissman, Valentina Cecchinato, Claudio Fenizia, Zhong-Min Ma, Robyn Washington Parks

J Virol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.
Ranajit Pal, David Venzon, Sampa Santra, Vaniambadi S Kalyanaraman, David C Montefiori, Robyn Washington Parks

J Virol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Zdenek Hel, Janos Nacsa, Elzbieta Tryniszewska, Wen-Po Tsai, Robyn Washington Parks

J Immunol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy.
Elzbieta Tryniszewska, Janos Nacsa, Mark G Lewis, Peter Silvera, David Montefiori, Robyn Washington Parks

J Immunol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis